Holds a Bachelor’s degree in Biomedical Sciences from the Federal University of Rio Grande do Norte, Brazil, with a background in undergraduate research on cancer and inflammation, focusing on nanoparticle-based cancer therapy.

Currently pursuing a Master’s degree by research at the South Australian Immunogenomics Cancer Institute (SAIGENCI), within the BioImmunoEngineering Laboratory (BIEL). Research focuses on the development of lipid-polymer nanodiscs for mRNA delivery in cancer immunotherapy, aiming to enhance therapeutic efficacy.

Research interests include nanomedicine, immunotherapy, and drug delivery systems, particularly in oncology.